{"timeline":{"headline":"Triathlon Tritanium Knee Outcomes Study","type":"default","text":"History of NCT02155712","startDate":"2014,06,03","date": [{"startDate":"2014,06,03","headline":"View of NCT02155712 on 2014_06_03","text":"<table class=\"info\">\n<tr>\n<th nowrap=\"\">ClinicalTrials Identifier:</th><td>NCT02155712</td>\n</tr>\n<tr>\n<th>Updated:</th><td>2014_06_03</td>\n</tr>\n<tr>\n<th class=\"section\" colspan=\"2\">\n<h2>Descriptive Information</h2>\n</th>\n</tr>\n<tr>\n<th>Brief title</th><td>\n<p>Triathlon Tritanium Knee Outcomes Study</p>\n</td>\n</tr>\n<tr>\n<th>Official title</th><td>\n<p>Triathlon Tritanium Knee Outcomes Study</p>\n</td>\n</tr>\n<tr>\n<th>Brief summary</th>\n</tr>\n<tr>\n<td class=\"bigdent\" colspan=\"2\">\n<p>The success rate of the Triathlon Tritanium Knee, defined as absence of revision for aseptic loosening of the tibial baseplate at 2 years, is no worse than rates reported in the literature for cemented devices.</p>\n</td>\n</tr>\n<tr>\n<th>Detailed description</th>\n</tr>\n<tr>\n<td class=\"bigdent\" colspan=\"2\">\n<p></p>\n</td>\n</tr>\n<tr>\n<th>Phase</th><td>N/A</td>\n</tr>\n<tr>\n<th>Study type</th><td>Interventional</td>\n</tr>\n<tr>\n<th>Study design</th><td>Treatment</td>\n</tr>\n<tr>\n<th>Study design</th><td>Non-Randomized</td>\n</tr>\n<tr>\n<th>Study design</th><td>Open Label</td>\n</tr>\n<tr>\n<th>Study design</th><td>Parallel Assignment</td>\n</tr>\n<tr>\n<th>Study design</th><td>Safety/Efficacy Study</td>\n</tr>\n<tr>\n<th>Primary outcome</th><td>Measure: Rate of Aseptic Loosening (baseplate)<br/>Time Frame: 2 years<br/>Safety Issue? Yes</td>\n</tr>\n<tr>\n<th>Secondary outcome</th><td>Measure: Implant Survivorship (baseplate and patella)<br/>Time Frame: 10 years<br/>Safety Issue? Yes</td>\n</tr>\n<tr>\n<th>Secondary outcome</th><td>Measure: 2011 Knee Society Score (KSS)<br/>Time Frame: 2 years<br/>Safety Issue? No</td>\n</tr>\n<tr>\n<th>Secondary outcome</th><td>Measure: Oxford Knee Score (OKS)<br/>Time Frame: 2 years<br/>Safety Issue? No</td>\n</tr>\n<tr>\n<th>Secondary outcome</th><td>Measure: Short Form-12 (SF-12)<br/>Time Frame: 2 years<br/>Safety Issue? No</td>\n</tr>\n<tr>\n<th>Condition</th><td>\n         Arthroplasty, Replacement, Knee\n      </td>\n</tr>\n<tr>\n<th>Arm/Group</th><td>\n<div>Arm Label: Triathlon Tritanium Knee      \n            \u00a0 \u00a0 \u00a0 \u00a0\n        Active Comparator</div>\n<p></p>\n</td>\n</tr>\n<tr>\n<th>Arm/Group</th><td>\n<div>Arm Label: Triathlon Knee      \n            \u00a0 \u00a0 \u00a0 \u00a0\n        Active Comparator</div>\n<p></p>\n</td>\n</tr>\n<tr>\n<th>Intervention</th><td>\n<div>Device: Triathlon Tritanium Knee\n            \u00a0 \u00a0 \u00a0 \u00a0\n            Arm Label: Triathlon Tritanium Knee</div>\n<p>Cementless</p>\n</td>\n</tr>\n<tr>\n<th>Intervention</th><td>\n<div>Device: Triathlon Knee\n            \u00a0 \u00a0 \u00a0 \u00a0\n            Arm Label: Triathlon Knee</div>\n<p>Cemented</p>\n</td>\n</tr>\n<tr>\n<th class=\"section\" colspan=\"2\">\n<h2>Recruitment Information</h2>\n</th>\n</tr>\n<tr>\n<th>Status</th><td>Not yet recruiting</td>\n</tr>\n<tr>\n<th>Last follow-up date</th><td>\n         2027-12\n      \n      (Anticipated)\n  </td>\n</tr>\n<tr>\n<th>Primary completion date</th><td>\n         2019-12\n      \n      (Anticipated)\n  </td>\n</tr>\n<tr>\n<th>Criteria</th>\n</tr>\n<tr>\n<td class=\"bigdent\" colspan=\"2\">\n<p>Inclusion Criteria:<br/>1.\tPatient has signed an Institutional Review Board (IRB)/Ethics Committee (EC) approved; study specific Informed Patient Consent Form.<br/>2.\tPatient is a male or non-pregnant female age 18-75 years at time of study device implantation.<br/>3.\tPatient has a diagnosis of Non-Inflammatory Degenerative Joint Disease (NIDJD).<br/>4.\tPatient is a candidate for primary cementless total knee replacement, including a resurfaced patella.<br/>5.\tPatient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.<br/>\n<br/>\n<br/>Exclusion Criteria:<br/>1.\tPatient has a Body Mass Index (BMI) &gt; 40.<br/>2.\tPatient has a diagnosis of avascular necrosis or inflammatory arthritis.<br/>3.\tPatient has an active or suspected latent infection in or about the affected knee joint at time of study device implantation.<br/>4.\tPatient has a neuromuscular or neurosensory deficiency, which limits the ability to evaluate the safety and efficacy of the device.<br/>5.\tSubject is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic disorder (e.g. Paget's Disease) leading to progressive bone deterioration.<br/>6.\tPatient is immunologically suppressed or receiving steroids in excess of normal physiological requirements (e.g. &gt; 30 days).<br/>7.\tPatient is diagnosed with lumbar radicular pain.<br/>8.\tPatient has a known sensitivity to device materials.<br/>9.\tPatient is a prisoner.</p>\n</td>\n</tr>\n<tr>\n<th>Gender</th><td>\n            Both\n         </td>\n</tr>\n<tr>\n<th>Minimum age</th><td>18 Years</td>\n</tr>\n<tr>\n<th>Maximum age</th><td>75 Years</td>\n</tr>\n<tr>\n<th>Healthy volunteers</th><td>No</td>\n</tr>\n<tr>\n<th class=\"section\" colspan=\"2\">\n<h2>Administrative Data</h2>\n</th>\n</tr>\n<tr>\n<th>Organization name</th><td>Stryker Orthopaedics</td>\n</tr>\n<tr>\n<th>Organization study ID</th><td>74</td>\n</tr>\n<tr>\n<th>Sponsor</th><td>\n               Stryker Orthopaedics\n            </td>\n</tr>\n<tr>\n<th>Health Authority</th><td>\n               United States: Institutional Review Board\n         </td>\n</tr>\n</table>","asset":{"media":"","credit":"clinicaltrials.gov","caption":""}}]}}